2m 2m 2m 2m 2m 2m 2m
CARIS (CAI)
NASDAQ
$16.75-$0.31 (-1.81%)
Price as of Jul 14, 2026 4:42 AM EDT- $4.8BMarket Cap
- -38.46%1-Year Change
- BiotechnologyIndustry
CARIS (CAI)
$16.75-$0.31 (-1.81%)
CAI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.06 | ||
Change | +$0.07 (+0.41%) | ||
Open | $17.10 | ||
High | $17.32 | ||
Low | $16.38 | ||
Previous Close | $16.99 | ||
Volume | 4,267,049 | ||
30-Day Average Volume | 3,150,732 | ||
1-Week Change | -4.21% | ||
1-Month Change | -5.06% | ||
1-Year Change | -38.46% | ||
3-Year Change | -69.54% | ||
5-Year Change | -69.18% | ||
Fundamentals | |||
Shares Outstanding | 282.7M | ||
Total Assets | $1.2B | ||
Market Cap | $4.8B | ||
Enterprise Value | $4.4B | ||
Period: QTR TTM FY | |||
Revenue | $210.8M | ||
Net Income | -$510,000.00 | ||
Free Cash Flow | $22.5M | ||
EBIT | $12.2M | ||
EBITDA | $17.2M | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | 253 | ||
Enterprise Value/Revenue | 21 | ||
P/B | 8 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | 213 | ||
Price/Operating Cash Flow | 146 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 09/09/2021 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield